Marchetti B, Bilel S, Tirri M, Corli G, Roda E, Locatelli C
Int J Mol Sci. 2023; 24(8).
PMID: 37108687
PMC: 10142259.
DOI: 10.3390/ijms24087515.
Krishnaswamy S, Rane M, Gaziano J, Hennekens C
Cureus. 2021; 13(4):e14624.
PMID: 34055502
PMC: 8144072.
DOI: 10.7759/cureus.14624.
Herrera J, Ward C, Pitcher M, Percy A, Skinner S, Kaufmann W
Dis Model Mech. 2015; 8(4):363-71.
PMID: 25713300
PMC: 4381335.
DOI: 10.1242/dmm.020131.
Sobansky M, Hage D
Anal Bioanal Chem. 2014; 406(25):6203-11.
PMID: 25103529
PMC: 4167910.
DOI: 10.1007/s00216-014-8081-4.
Bowyer A
Calif Med. 1970; 112(2):58.
PMID: 18730252
PMC: 1501694.
The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmias.
Fechter P, Ha H, Follath F, Nager F
Eur J Clin Pharmacol. 1983; 25(6):729-34.
PMID: 6662171
DOI: 10.1007/BF00542510.
Beta-adrenergic blockade and cardiac arrhythmias.
SLOMAN G, Stannard M
Br Med J. 1967; 4(5578):508-12.
PMID: 6065983
PMC: 1749176.
DOI: 10.1136/bmj.4.5578.508.
Modification of cardiovascular responses by propranolol.
VOGEL J, BLOUNT Jr S
Br Heart J. 1967; 29(3):310-6.
PMID: 6023724
PMC: 459151.
DOI: 10.1136/hrt.29.3.310.
Conversion of atrial fibrillation and flutter by propranolol.
Wolfson S, Herman M, Sullivan J, Gorlin R
Br Heart J. 1967; 29(3):305-9.
PMID: 6023723
PMC: 459150.
DOI: 10.1136/hrt.29.3.305.
Hemodynamic response to exercise after beta-adrenergic blockade with propranolol in patients with mitral valve obstruction.
Cummung G, Carr W
Can Med Assoc J. 1966; 95(10):527-31.
PMID: 5955714
PMC: 1935648.
Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba.
Grandjean T, RIVIER J
Br Heart J. 1968; 30(1):50-9.
PMID: 5637558
PMC: 459207.
DOI: 10.1136/hrt.30.1.50.
Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.
Sandler G, Pistevos A
Br Med J. 1971; 1(5743):254-7.
PMID: 5100496
PMC: 1794979.
DOI: 10.1136/bmj.1.5743.254.
Effect of propranolol on exercise tolerance of patients with atrial fibrillation.
Brown R, GOBLE A
Br Med J. 1969; 2(5652):279-80.
PMID: 4888876
PMC: 1983196.
DOI: 10.1136/bmj.2.5652.279.
Effect of -adrenoceptor blocking agents on poststimulatory atrial flutter in the dog, with observations on the participation of adrenergic mechanisms in this experimental arrhythmia.
MADAN B, Soni R
Br J Pharmacol. 1972; 44(1):109-16.
PMID: 4401305
PMC: 1665701.
DOI: 10.1111/j.1476-5381.1972.tb07243.x.
Beta blockade in flutter.
Br Med J. 1970; 4(5736):636.
PMID: 4395142
PMC: 1820281.
[Adrenergic alpha and beta receptors and their specific inhibitors].
Muscholl E, Rahn K
Klin Wochenschr. 1968; 46(3):113-9.
PMID: 4385910
DOI: 10.1007/BF01727368.
A trial of propranolol in myocardial infarction.
Ledwich J
Can Med Assoc J. 1968; 98(21):988-94.
PMID: 4174139
PMC: 1924169.
The drug treatment of atrial fibrillation.
Channer K
Br J Clin Pharmacol. 1991; 32(3):267-73.
PMID: 1685662
PMC: 1368517.
DOI: 10.1111/j.1365-2125.1991.tb03898.x.
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Anderson J, Harrison D, Meffin P, Winkle R
Drugs. 1978; 15(4):271-309.
PMID: 648399
DOI: 10.2165/00003495-197815040-00003.
